MCID: NNT006
MIFTS: 26

Neonatal Myasthenia Gravis malady

Categories: Immune diseases, Neuronal diseases, Fetal diseases, Bone diseases, Rare diseases

Aliases & Classifications for Neonatal Myasthenia Gravis

About this section

Aliases & Descriptions for Neonatal Myasthenia Gravis:

Name: Neonatal Myasthenia Gravis 10 12
 
Myasthenia Gravis, Neonatal 36

Classifications:



External Ids:

Disease Ontology10 DOID:14043
ICD9CM29 775.2
SNOMED-CT59 82178003
MeSH36 D020941
UMLS65 C0158982

Summaries for Neonatal Myasthenia Gravis

About this section
MalaCards based summary: Neonatal Myasthenia Gravis, also known as myasthenia gravis, neonatal, is related to interstitial lung disease and transient neonatal myasthenia gravis. An important gene associated with Neonatal Myasthenia Gravis is CHRNG (Cholinergic Receptor Nicotinic Gamma Subunit). Affiliated tissues include endothelial, brain and myeloid, and related mouse phenotypes are respiratory system and mortality/aging.

Related Diseases for Neonatal Myasthenia Gravis

About this section

Graphical network of the top 20 diseases related to Neonatal Myasthenia Gravis:



Diseases related to neonatal myasthenia gravis

Symptoms for Neonatal Myasthenia Gravis

About this section

Drugs & Therapeutics for Neonatal Myasthenia Gravis

About this section

Drugs for Neonatal Myasthenia Gravis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cyclophosphamideapproved, investigationalPhase 1264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide

Interventional clinical trials:

idNameStatusNCT IDPhase
1Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisActive, not recruitingNCT00424489Phase 1

Search NIH Clinical Center for Neonatal Myasthenia Gravis


Cochrane evidence based reviews: myasthenia gravis, neonatal

Genetic Tests for Neonatal Myasthenia Gravis

About this section

Anatomical Context for Neonatal Myasthenia Gravis

About this section

MalaCards organs/tissues related to Neonatal Myasthenia Gravis:

33
Endothelial, Brain, Myeloid, T cells, Lung, Prostate, Testes

Animal Models for Neonatal Myasthenia Gravis or affiliated genes

About this section

MGI Mouse Phenotypes related to Neonatal Myasthenia Gravis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.7AQP4, CHRNG, MB, MUSK
2MP:00107687.0AFP, AQP4, CHRNG, DPAGT1, MB, MUSK

Publications for Neonatal Myasthenia Gravis

About this section

Articles related to Neonatal Myasthenia Gravis:

(show all 43)
idTitleAuthorsYear
1
Long-term outcome in selective dorsal rhizotomy in spastic cerebral palsy: differentiation in mobility levels is needed. (25616014)
2015
2
Rhombencephalosynapsis as a cause of aqueductal stenosis: an under-recognized association in hydrocephalic children. (24633306)
2014
3
Effect of oropharyngeal povidone-iodine preventive oral care on ventilator-associated pneumonia in severely brain-injured or cerebral hemorrhage patients: a multicenter, randomized controlled trial*. (24105456)
2014
4
False positive malaria rapid diagnostic test in returning traveler with typhoid fever. (25005493)
2014
5
Preliminary X-ray crystallographic studies of the short form of the human TRAF4 TRAF domain. (23908043)
2013
6
Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. (22653439)
2013
7
Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism. (23569134)
2013
8
Carbamazepine use in pregnancy and coincidental thalidomide-like phocomelia in a newborn. (22663328)
2012
9
Comparison between dual-energy X-ray absorptiometry and skinfolds thickness in assessing body fat in anorexia nervosa before and after weight restoration. (22513184)
2012
10
PP1A-mediated dephosphorylation positively regulates YAP2 activity. (21909427)
2011
11
The role of secreted frizzled-related protein 2 expression in prostate cancer. (22175903)
2011
12
Laboratory diagnosis of tuberculous meningitis - is there a scope for further improvement? (21814402)
2010
13
Jaw osteomyelitis as a complication in osteopetrosis. (20072016)
2010
14
Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization. (19580349)
2009
15
Profiling microRNA expression: a snapshot of nonalcoholic steatohepatitis and a recording of its pathogenesis. (19127512)
2009
16
Extracorporeal membrane oxygenation for neonatal respiratory failure. (19712500)
2009
17
Defining "prodromal" Alzheimer's disease, frontotemporal dementia, and Lewy body dementia: are we there yet? (18327642)
2008
18
Unsuccessful treatment attempt: cord blood stem cell transplantation in a patient with Niemann-Pick disease type A. (17960492)
2007
19
Association of epidermal growth factor receptor mutations in lung cancer with chemosensitivity to gefitinib in isolated cancer cells from Japanese patients. (17508947)
2007
20
Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese population. (17719609)
2007
21
IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. (16304057)
2006
22
Analysis of tumor necrosis factor-alpha, transforming growth factor-beta, interleukin-10, IL-6, and interferon-gamma gene polymorphisms in patients with chronic periodontitis. (17209781)
2006
23
Respiratory distress caused by a unilateral hydrothorax as only manifestation of ovarian hyperstimulation syndrome. (17000522)
2006
24
Nasal cytokines as mediators of illness during the common cold. (15842953)
2005
25
Alterations in expression of retinoid receptor beta and p53 in oral submucous fibrosis. (15196140)
2004
26
Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]. (15087031)
2004
27
Applied study on small-dose growth hormone supplement for aging-related symptom complex]. (15362524)
2004
28
Wnt-1 signaling inhibits human umbilical vein endothelial cell proliferation and alters cell morphology. (14644163)
2003
29
Membrane-associated serine/threonine protein phosphatase in endometrial cancer. (14710095)
2003
30
Repair of damaged and mismatched DNA by the XPC homologues Rhp41 and Rhp42 of fission yeast. (12807767)
2003
31
Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. (12731885)
2003
32
Development-related expression of AKAP79 in the striatal compartments of the human brain. (11275698)
2001
33
Glucose scavenging of nitric oxide. (11181410)
2001
34
Expression of vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor-beta (PDGFR-beta) in human gliomas. (10691304)
1999
35
Lack of gene- and strand-specific DNA repair in RNA polymerase III-transcribed human tRNA genes. (8972202)
1997
36
Keloid formation in syndactyly release: report of two cases. (9039671)
1997
37
Effects of ethanol administration on cerebral non-protein sulfhydryl content in rats exposed to styrene vapour. (8571382)
1996
38
Neuregulin receptors, erbB3 and erbB4, are localized at neuromuscular synapses. (8846777)
1995
39
Sequential high-dose combination chemotherapy with granulocyte colony-stimulating factor and peripheral blood progenitor cells in patients with solid tumors: intensification limited by nonhematologic toxic effects. (7693957)
1993
40
Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene. (1703303)
1991
41
Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjects. (2140925)
1990
42
Hemophilus orbital cellulitis and panophthalmitis simulating mucormycosis. (911115)
1977
43
Vagal impairment of gastric secretion in diabetic autonomic neuropathy. (1131624)
1975

Variations for Neonatal Myasthenia Gravis

About this section

Expression for genes affiliated with Neonatal Myasthenia Gravis

About this section
Search GEO for disease gene expression data for Neonatal Myasthenia Gravis.

Pathways for genes affiliated with Neonatal Myasthenia Gravis

About this section

GO Terms for genes affiliated with Neonatal Myasthenia Gravis

About this section

Sources for Neonatal Myasthenia Gravis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet